ConductScience.org, home
Confirmatory Study Nepafenac 0.3%
API referenceFor AI assistants

Trial · NCT01109173

Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Download this page as JSON
PeriodMilestoneGroupParticipantsUnits counted
Overall StudySTARTEDNepafenac 0.3%851
Overall StudySTARTEDNEVANAC845
Overall StudySTARTEDNepafenac Vehicle 0.3%211
Overall StudySTARTEDNEVANAC Vehicle213
Overall StudyCOMPLETEDNepafenac 0.3%763
Overall StudyCOMPLETEDNEVANAC759
Overall StudyCOMPLETEDNepafenac Vehicle 0.3%110
Overall StudyCOMPLETEDNEVANAC Vehicle120
Overall StudyNOT COMPLETEDNepafenac 0.3%88
Overall StudyNOT COMPLETEDNEVANAC86
Overall StudyNOT COMPLETEDNepafenac Vehicle 0.3%101
Overall StudyNOT COMPLETEDNEVANAC Vehicle93

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01109173/flow

API referenceFor AI assistants